SEC Tracker
Get the app

Rigel Pharmaceuticals RIGL

Rigel Pharmaceuticals says Dr. Brian Kotzin will resign

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Rigel Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float $300M to $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Amarin AMRN public float $335M, Jun 30, 2025
  2. Altimmune ALT public float $327M, Jun 30, 2025
  3. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  4. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  5. Nektar Therapeutics NKTR public float $318M, Jun 30, 2025